Indication

Zollinger-Ellison syndrome

Zollinger-Ellison syndrome is a rare neuroendocrine disorder characterized by the development of gastrin-secreting tumors, known as gastrinomas, which predominantly arise within the duodenum or pancreas. Read more about Zollinger-Ellison syndrome

502 drugs 204 manufacturers

Advertisement

Drugs that treat it

Common Zollinger-Ellison syndrome therapies.

Showing 118–126 of 502 drugs

LANSOPRAZOLE

PEPTIC ULCER AGENTS·ZOLLINGER-ELLISON SYNDROME·+13
SUNMARK

LANSOPRAZOLE

PEPTIC ULCER AGENTS·ZOLLINGER-ELLISON SYNDROME·+13
RUGBY

LANSOPRAZOLE

PEPTIC ULCER AGENTS·ZOLLINGER-ELLISON SYNDROME·+13
Major Pharamceuticals

LANSOPRAZOLE

PEPTIC ULCER AGENTS·ZOLLINGER-ELLISON SYNDROME·+13
CVS

LANSOPRAZOLE

PEPTIC ULCER AGENTS·ZOLLINGER-ELLISON SYNDROME·+13
TOPCO
Filter & compare in the drug finder →Opens the drug finder with Zollinger-Ellison syndrome preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Zollinger-Ellison syndrome.

Zollinger-Ellison syndrome is a rare neuroendocrine disorder characterized by the development of gastrin-secreting tumors, known as gastrinomas, which predominantly arise within the duodenum or pancreas.

These functional neoplasms autonomously produce excessive amounts of gastrin, stimulating gastric parietal cells to induce profound, uncontrolled gastric acid hypersecretion.

Pathophysiologically affecting the gastrointestinal tract, the resulting hyperchlorhydria commonly presents with severe, recurrent, or refractory peptic ulcer disease, gastroesophageal reflux, abdominal pain, and secretory diarrhea.

Zollinger-Ellison syndrome most frequently occurs sporadically, though roughly 20% to 25% of cases arise in association with the inherited autosomal dominant disorder multiple endocrine neoplasia type 1.

Personalize your experience

Follow Zollinger-Ellison syndrome and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it